Q1 EPS Estimates for Teladoc Health Lowered by William Blair

Teladoc Health, Inc. (NYSE:TDOC - Free Report) - Equities researchers at William Blair cut their Q1 2025 EPS estimates for Teladoc Health in a research note issued to investors on Wednesday, February 26th. William Blair analyst R. Daniels now anticipates that the health services provider will post earnings of ($0.31) per share for the quarter, down from their prior forecast of ($0.27). The consensus estimate for Teladoc Health's current full-year earnings is ($1.16) per share. William Blair also issued estimates for Teladoc Health's Q3 2025 earnings at ($0.18) EPS, Q4 2025 earnings at ($0.18) EPS and FY2025 earnings at ($0.88) EPS.

Other equities research analysts also recently issued research reports about the stock. Piper Sandler decreased their price target on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research note on Thursday, February 27th. Oppenheimer reduced their target price on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a research note on Friday, January 24th. Bank of America boosted their target price on shares of Teladoc Health from $11.50 to $13.50 and gave the company a "neutral" rating in a research note on Wednesday, February 12th. Royal Bank of Canada boosted their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Finally, Needham & Company LLC restated a "hold" rating on shares of Teladoc Health in a research note on Thursday, February 27th. Eleven research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $11.26.

Remove Ads

Teladoc Health Stock Performance

TDOC traded up $0.34 during trading on Monday, reaching $9.37. 13,570,918 shares of the company's stock were exchanged, compared to its average volume of 8,469,351. Teladoc Health has a fifty-two week low of $6.76 and a fifty-two week high of $15.95. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The business has a 50 day moving average price of $10.62 and a 200 day moving average price of $9.62. The company has a market capitalization of $1.63 billion, a P/E ratio of -1.62 and a beta of 1.27.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The business had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million.

Institutional Trading of Teladoc Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Brucke Financial Inc. bought a new stake in Teladoc Health during the 4th quarter worth about $92,000. Vise Technologies Inc. boosted its position in Teladoc Health by 4.9% during the 4th quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider's stock worth $274,000 after acquiring an additional 1,405 shares during the last quarter. PharVision Advisers LLC acquired a new position in Teladoc Health during the 4th quarter worth approximately $301,000. Twinbeech Capital LP boosted its position in Teladoc Health by 63.8% during the 4th quarter. Twinbeech Capital LP now owns 382,735 shares of the health services provider's stock worth $3,479,000 after acquiring an additional 149,118 shares during the last quarter. Finally, Two Sigma Advisers LP boosted its position in Teladoc Health by 213.0% during the 4th quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider's stock worth $20,532,000 after acquiring an additional 1,537,094 shares during the last quarter. 76.82% of the stock is owned by institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.